PedAM
Pediatric Disease Annotations & Medicines
| Disease | epilepsy |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 3 |
| PubMedID- 25078464 | Background: no study has explored the risk of metabolic syndrome (ms) in patients with epilepsy treated with valproate (vpa) at the population level. |
| PubMedID- 21685521 | According to our preliminary data vpa monotherapy increases the risk of metabolic syndrome in patients with epilepsy, but bmi did not differ between vpa monotherapy study group, cbz monotherapy study group and controls. |
| PubMedID- 23755911 | Purpose: to evaluate the association between the bsmi polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. |
Page: 1